KALA BIO
KALA
36 hedge funds and large institutions have $80.7M invested in KALA BIO in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 2 closing their positions.
1,025% more call options, than puts
Call options by funds: $2.25M | Put options by funds: $200K
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
48% more capital inflows, than outflows
Capital inflows: $15.1M | Capital outflows: $10.1M
0% more funds holding
Funds holding: 36 → 36 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.91% less ownership
Funds ownership: 65.24% → 63.33% (-1.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
+$1.74M |
| 2 |
Pura Vida Investments
New York
|
+$869K |
| 3 |
Sofinnova Investments
Menlo Park,
California
|
+$869K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$290K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$290K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.55M |
| 2 |
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$2.32M |
| 3 |
BlackRock
New York
|
-$1.16M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$290K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$290K |
KALA Hedge Fund Activity: Q4 2019 in Review
36 of the 5,095 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2019, worth a combined $80.7M — down 4.4% from $84.4M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new KALA positions and 2 closed out — a net gain of 1 holder — while 9 added to existing stakes and 4 trimmed.
The largest buyer was First Manhattan, opening a new position worth an estimated $1.74M. The largest seller was Wellington Management Group, exiting entirely with an estimated $5.55M sold.
- 36 institutional investors held KALA BIO (KALA) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $80.7M of KALA BIO stock for Q4 2019, down 4.4% quarter-over-quarter.
- 3 funds opened new KALA BIO positions in Q4 2019 and 2 closed out, a net change of +1 holder.
- The largest KALA BIO buyer in Q4 2019 was First Manhattan, an estimated $1.74M added.
- The largest KALA BIO seller in Q4 2019 was Wellington Management Group, an estimated $5.55M sold.
Based on aggregated 13F filings for Q4 2019.